Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Leaky vaccines help reduce transmission of Marek’s disease
Leaky vaccines are currently the most commonly used method of controlling Marek's disease.

Study finds imperfect vaccines control severity of viral disease

A new study conducted on chickens infected with Marek’s disease has revealed that vaccines that do not prevent onward transmission or infection are more effective in controlling the severity of the disease than previously thought.

Researchers from the University of Edinburgh’s Roslin Institute and the US Department of Agriculture’s Avian Disease and Oncology laboratory (ADOL), conducted the study to analyse how leaky vaccines impact overall populations.

One group of chickens received a leaky vaccine – this contained a related live virus originating from turkeys, which triggers an immune response, but no symptoms. While a second control group was given a sham vaccine, which contained no biological material. Both groups were then infected with Marek’s disease virus and placed with different sets of unvaccinated chickens for 48 hours.

More than 97 per cent of the birds became infected. However, the unvaccinated chickens that had contact with those who had received the leaky vaccine were less likely to develop full-blown Marek’s disease and there were also fewer deaths. This was found to be a result of vaccinated birds transmitting fewer copies of Marek’s disease virus.

Lead author Dr Richard Bailey, who is also a research fellow at the Roslin Institute, said: “In our study, we found that leaky vaccines can provide benefit in terms of reducing the presence and severity of symptoms, and mortality, caused by Marek’s disease even for unvaccinated chickens. We need further research to understand how this effect changes as the virus mutates and in other strains of chickens.” 

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.